Lineage Cell Therapeutics Inc. — Director's Dealing 2012

Jul 3, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOTIME INC (BTX)
CIK: 0000876343
Period of Report: 2012-07-01

Reporting Person: BROADWOOD PARTNERS LP (Director, 10% Owner)
Reporting Person: BROADWOOD CAPITAL INC (10% Owner)
Reporting Person: BRADSHER NEAL C (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-07-01	Options to Purchase Common Shares	$4.60	A	20000	Acquired	2017-06-30	Common Shares (20000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase Common Shares	$5.13	2016-06-30	Common Shares (20000)	20000	Direct
Option to Purchase Common Shares	$5.45	2015-08-09	Common Shares (20000)	20000	Direct
Option to Purchase Common Shares	$2.30	2014-07-01	Common Shares (20000)	20000	Direct

Footnotes

F1: These options will vest and become exercisable in four quarterly installments, provided that Neal C. Bradsher remains a director on the last day of each quarter.

F2: The options were granted to Neal C. Bradsher by the issuer on July 1, 2012 as director compensation pursuant to the issuer's 2002 Stock Option Plan, as amended.

F3: These securities are owned by Neal C. Bradsher, who is a Reporting Person.